| Literature DB >> 31877142 |
Bruno Tardelli Diniz Nunes1,2, Maria Helena Rodrigues de Mendonça1, Darlene de Brito Simith1,2, Adriana Freitas Moraes1, Carla Conceição Cardoso1, Ivy Tsuya Essashika Prazeres1, Ana Alice de Aquino1, Alessandra da Conceição Miranda Santos1, Alice Louize Nunes Queiroz1, Daniela Sueli Guerreiro Rodrigues1, Regis Bruni Andriolo3, Elizabeth Salbé Travassos da Rosa1, Livia Carício Martins1, Pedro Fernando da Costa Vasconcelos1,2, Daniele Barbosa de Almeida Medeiros1,2.
Abstract
Hantavirus Pulmonary Syndrome is an, often fatal, emerging zoonotic disease in the Americas caused by hantaviruses (family: Hantaviridae). In Brazil, hantavirus routine diagnosis is based on serology (IgM-ELISA) while RT-PCR is often used to confirm acute infection. A Semi-nested RT-PCR and an internally controlled RT-qPCR assays were developed for detection and quantification of four hantaviruses strains circulating in the Brazilian Amazon: Anajatuba (ANAJV) and Castelo dos Sonhos (CASV) strains of Andes virus (ANDV) species; and Rio Mamoré (RIOMV) and Laguna Negra (LNV) strains of LNV species. A consensus region in the N gene of these hantaviruses was used to design the primer sets and a hydrolysis probe. In vitro transcribed RNA was diluted in standards with known concentration. MS2 bacteriophage RNA was detected together with hantavirus RNA as an exogenous control in a duplex reaction. RT-qPCR efficiency was around 100% and the limit of detection was 0.9 copies/μL of RNA for RT-qPCR and 10 copies/μL of RNA for Semi-nested RT-PCR. There was no amplification of either negative samples or samples positive to other pathogens. To assess the protocol for clinical sensitivity, specificity and general accuracy values, both assays were used to test two groups of samples: one comprising patients with disease (n = 50) and other containing samples from healthy individuals (n = 50), according to IgM-ELISA results. A third group of samples (n = 27) infected with other pathogens were tested for specificity analysis. RT-qPCR was more sensitive than semi-nested RT-PCR, being able to detect three samples undetected by conventional RT-PCR. RT-qPCR clinical sensitivity, specificity and general accuracy values were 92.5%, 100% and 97.63%, respectively. Thus, the assays developed in this study were able to detect the four Brazilian Amazon hantaviruses with good specificity and sensitivity, and may become powerful tools in diagnostic, surveillance and research applications of these and possibly other hantaviruses.Entities:
Mesh:
Year: 2019 PMID: 31877142 PMCID: PMC6932758 DOI: 10.1371/journal.pntd.0007884
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Nucleotide sequences of primers and probes used in hantavirus RT-qPCR and Nested RT-PCR assays.
| Primer/Probe | Sequence (5'-3') | Position | Amplicon |
|---|---|---|---|
| HTNgen145F | GCAGCTGTGTCTACATTGGAGAA | 145–167 | 90 bp |
| HTNgen234R | TGGTTTTGAAGCCAGTTTTTGA | 213–234 | |
| HTNgen169p | 169–197 | ||
| MS2 F | CATAAGTTAGATGGCCGTCTGT | 841–863 | 123 bp |
| MS2 R | TAGAGACGACAACCATGCCAAAC | 941–964 | |
| MS2 probe | 881–992 | ||
| HTN_73F | CT | 73–93 | 890 bp |
| HTN_963R | AACATAAAGTGCAGTTGG | 943–963 | |
| HTN_314R | TTGACATC | 294–314 | 241 bp |
Virus and other pathogens tested for specificity.
| Pathogen | Sample type |
|---|---|
| human blood | |
| human serum | |
| human blood | |
| human serum | |
| suckling mice brain | |
| suckling mice brain | |
| suckling mice brain | |
| cell culture | |
| cell culture | |
| cell culture | |
| cell culture | |
| cell culture | |
| cell culture | |
| suckling mice brain | |
| suckling mice brain | |
| suckling mice brain | |
| suckling mice brain | |
| suckling mice brain | |
| suckling mice brain | |
| suckling mice brain | |
| cell culture | |
| cell culture | |
| cell culture | |
| human blood | |
| goat blood | |
| yeast culture |
Fig 1Comparison between amplification efficiencies of hantavirus RT-qPCR in singleplex and multiplex with MS2 EIC formats.
Amplification plot and Standard Curve for each assay format are depicted. Threshold was fixed where the amplification efficiency was higher, inside the exponential phase of each amplification plot in logarithmic scale, with 0.3481 ΔRn in singleplex (A) and 0.4492 ΔRn in multiplex (B). Ct variation between singleplex and multiplex was within 1 Ct. Standard curves were constructed with seven 1:10 dilutions ranging from 107 copies to 101 copies of in vitro RNA. Amplification efficiency was 97.6% for singleplex (R2:0.999) (A) and 97.7% for multiplex (R2:0.998) (B). Ct: Cycle threshold, HTN M: hantavirus RT-qPCR multiplex format, HTN S: hantavirus RT-qPCR singleplex format.
Detection limit of hantavirus RT-qPCR and Semi-nested RT-PCR assays.
| RNA copies/reaction | VGE/mL | RT-qPCR | Semi-nested RT-PCR | |
|---|---|---|---|---|
| positive/tested | Interpretation | |||
| 102 | 2x103 | 3/3 | Positive | Positive |
| 10 | 200 | 3/3 | Positive | Negative |
| 9 | 180 | 6/6 | Positive | Negative |
| 8 | 160 | 4/6 | Negative | Negative |
| 7 | 140 | 4/6 | Negative | Negative |
| 6 | 120 | 0/6 | Negative | Negative |
| 5 | 100 | 3/6 | Negative | Negative |
| 4 | 80 | 0/6 | Negative | Negative |
| 3 | 60 | 1/6 | Negative | Negative |
| 2 | 40 | 1/6 | Negative | Negative |
| 1 | 20 | 1/6 | Negative | Negative |
| NC | NA | 0/6 | Negative | Negative |
| NTC | NA | 0/6 | Negative | Negative |
VGE: viral genome equivalents; Ct: cycle threshold; NC: negative control; NTC: no template control; NA: not Applicable; Ind: indeterminate
Fig 2Agarose gel electrophoresis of hantavirus Semi-nested RT-PCR amplification products from clinical samples positive for IgM-ELISA.
Agarose gel (1.5%) stained with SYBR safe dye were run for 50 min at 120V in TBE buffer. Each lane was loaded with 5μL of sample diluted in BlueJuice™ Gel Loading Buffer (Invitrogen). NTC: No template Control, S1-6: sample 1–6, PC: Positive Control, MW: Molecular weight (100bp DNA Ladder—Invitrogen).
Epidemiological data from hantavirus IgM-ELISA positive samples collected from symptomatic patients between 2003 and 2012 used in the clinical sensitivity/specificity panel.
| # | DIAGNOSTIC ASSAYS RESULTS | EPIDEMIOLOGICAL DATA | ||||
|---|---|---|---|---|---|---|
| IgG | Semi-nested | RT-qPCR Quantification | Disease time (days) | Clinical Manifestations | Year | |
| 01 | Positive | Positive | <2x103 | 2 | NI | 2006 |
| 02 | Positive | Positive | <2x103 | 3 | NI | 2006 |
| 03 | Positive | Positive | <2x103 | 6 | NI | 2006 |
| 04 | Positive | Positive | 3.8x105 | 4 | NI | 2006 |
| 05 | Negative | Positive | 1.8x105 | 4 | NI | 2006 |
| 06 | Negative | Positive | <2x103 | NA | None (contact) | 2006 |
| 07 | Negative | Positive | 1.6x105 | NI | Death | 2006 |
| 08 | Positive | Positive | 3.8x104 | NI | NI | 2006 |
| 09 | Positive | Positive | 8.1x105 | 3 | NI | 2007 |
| 10 | Positive | Positive | 1.8x104 | 1 | Subclinical | 2007 |
| 11 | Positive | Positive | <2x103 | 9 | HPS | 2007 |
| 12 | Positive | Negative | Negative | 8 | NI | 2008 |
| 13 | Negative | Positive | <2x103 | 6 | Prodrome | 2008 |
| 14 | Negative | Negative | Negative | 3 | NI | 2008 |
| 15 | Negative | Negative | Negative | 3 | NI | 2008 |
| 16 | Negative | Negative | Negative | 6 | HPS | 2008 |
| 17 | Positive | Positive | 1.1x104 | 6 | Prodrome | 2008 |
| 18 | Positive | Positive | <2x103 | 5 | HPS | 2008 |
| 19 | Positive | Negative | Negative | NI | NI | 2006 |
| 20 | Negative | Negative | <2x103 | 4 | Prodrome | 2008 |
| 21 | Negative | Negative | <2x103 | 4 | Prodrome | 2008 |
| 22 | Negative | Positive | <2x103 | 3 | Prodrome | 2008 |
| 23 | Negative | Negative | Negative | 5 | Death | 2008 |
| 24 | Positive | Positive | 1.3x105 | NI | NI | 2006 |
| 25 | Positive | Negative | Negative | 1 | NI | 2009 |
| 26 | Positive | Negative | Negative | 5 | Neurologic | 2009 |
| 27 | Positive | Positive | <2x103 | 7 | NI | 2009 |
| 28 | Positive | Negative | Negative | 2 | NI | 2009 |
| 29 | Negative | Positive | 1.2x106 | NI | NI | 2009 |
| 30 | Negative | Positive | <2x103 | 6 | NI | 2007 |
| 31 | Positive | Negative | Negative | 11 | NI | 2009 |
| 32 | Positive | Positive | 3.5x105 | 3 | Death | 2009 |
| 33 | Positive | Positive | <2x103 | 4 | Prodrome | 2009 |
| 34 | Positive | Positive | <2x103 | 5 | NI | 2010 |
| 35 | Positive | Positive | <2x103 | NI | NI | 2007 |
| 36 | Positive | Positive | <2x103 | 4 | NI | 2010 |
| 37 | Positive | Positive | 5.4x103 | 7 | NI | 2010 |
| 38 | Positive | Positive | <2x103 | 3 | NI | 2010 |
| 39 | Positive | Positive | 1.0x105 | 4 | Prodrome | 2010 |
| 40 | Positive | Positive | 9.0x104 | 5 | NI | 2010 |
| 41 | Positive | Positive | <2x103 | 7 | Prodrome | 2010 |
| 42 | Positive | Positive | 2.4x103 | 3 | Prodrome | 2010 |
| 43 | Positive | Positive | <2x103 | NI | Death | 2010 |
| 44 | Positive | Positive | <2x103 | 5 | NI | 2010 |
| 45 | Negative | Positive | 1.2x104 | NI | Prodrome | 2008 |
| 46 | Positive | Positive | <2x103 | 6 | Prodrome | 2011 |
| 47 | Negative | Negative | <2x103 | NI | NI | 2008 |
| 48 | Positive | Positive | <2x103 | NI | Death | 2012 |
| 49 | Positive | Positive | <2x103 | 7 | Death | 2012 |
| 50 | Positive | Positive | <2x103 | NA | None (contact) | 2012 |
NA: not applicable; NI: not informed; HPS: hantavirus pulmonary syndrome. Prodrome: non-specific influenza-like symptoms stage; Subclinical: contact patients with no symptoms; Neurologic: patients with neurologic manifestations such as encephalitis and meningitis.
Contingency table showing the results obtained by Semi-nested RT-PCR compared with those obtained by IgM-ELISA as reference assay.
| IgM-ELISA | ||||
|---|---|---|---|---|
| Positive | Negative | Total | ||
| Semi-nested | Positive | 37 | 0 | 37 |
| Negative | 13 | 50 | 63 | |
| Total | 50 | 50 | 100 | |
| Performance Measures | Value | κ index | ||
| Sensitivity | 74.00% | 0.74 | ||
| Specificity | 100.00% | |||
| PPV | 100.00% | |||
| NPV | 79.37% | |||
| FP | 0.00% | |||
| FN | 26.00% | |||
| Accuracy | 87.00% | |||
*95% Confidence interval. PPV: positive predictive value, NPV: negative predictive value, FP: False-positive, FN: False-negative.
Contingency table showing the results obtained by RT-qPCR compared with those obtained by IgM-ELISA as reference assay.
| IgM-ELISA | ||||
|---|---|---|---|---|
| Positive | Negative | Total | ||
| RT-qPCR | Positive | 40 | 0 | 40 |
| Negative | 10 | 50 | 60 | |
| Total | 50 | 50 | 100 | |
| Performance Measures | Value | κ index | ||
| Sensitivity | 80.00% | 0.80 | ||
| Specificity | 100.00% | |||
| PPV | 100.00% | |||
| NPV | 83.33% | |||
| FP | 0.00% | |||
| FN | 20.00% | |||
| Accuracy | 90.00% | |||
*95% Confidence interval. PPV: positive predictive value, NPV: negative predictive value, FP: False-positive, FN: False-negative.
Contingency table showing the results obtained by Semi-nested RT-PCR compared with those obtained by RT-qPCR as reference assay.
| RT-qPCR | ||||
|---|---|---|---|---|
| Positive | Negative | Total | ||
| Semi-nested | Positive | 37 | 0 | 37 |
| Negative | 3 | 87 | 90 | |
| Total | 40 | 87 | 127 | |
| Performance Measures | Value | κ index | ||
| Sensitivity | 92.50% | 0.94 | ||
| Specificity | 100.00% | |||
| PPV | 100.00% | |||
| NPV | 96.67% | |||
| FP | 0.00% | |||
| FN | 7.50% | |||
| Accuracy | 97.64% | |||
*95% Confidence interval. PPV: positive predictive value, NPV: negative predictive value, FP: False-positive, FN: False-negative.